Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics (April 18, 2006). doi:10.1152/physiolgenomics.00300.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/2/116    most recent
00300.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dawson, P. A
Right arrow Articles by Markovich, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dawson, P. A
Right arrow Articles by Markovich, D.
Submitted on December 6, 2005
Accepted on April 12, 2006

Transcriptional profile reveals altered hepatic lipid and cholesterol metabolism in hyposulfatemic NaS1 null mice

Paul A Dawson1, Brooke Gardiner2, Sean Grimmond3, and Daniel Markovich1*

1 School of Biomedical Sciences, University of Queensland, Brisbane, Australia
2 Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia
3 University of Queensland, Institute for Molecular Bioscience, St Lucia, Australia

* To whom correspondence should be addressed. E-mail: d.markovich{at}uq.edu.au.

Sulfate plays an essential role in human growth and development, and its circulating levels are maintained by the renal Na+-SO42- cotransporter, NaS1. We previously generated a NaS1 knock-out (N{alpha}s1-/-) mouse, an animal model for hyposulfatemia, which exhibits reduced growth and liver abnormalities, including hepatomegaly. In this study, we investigated the hepatic gene expression profile of N{alpha}s1-/- mice using oligonucleotide microarrays. The mRNA expression level of 92 genes with known functional roles in metabolism, cell signaling, cell defense, immune response, cell structure, transcription or protein synthesis, were increased (n=51) or decreased (n=41) in N{alpha}s1-/- mice when compared with N{alpha}s1+/+ mice. The most up-regulated transcript levels in N{alpha}s1-/- mice were found for the sulfotransferase genes, Sult3{alpha}1 ({approx}500% increase) and Sult2{alpha}2 (100% increase), whereas the metallothionein-1 gene, Mt1, was amongst the most down-regulated genes (70% decrease). Several genes involved in lipid and cholesterol metabolism, including Scd1, Acly, Gp{alpha}m, Elov16, Acsl5, Mvd, Insig1 and Apo{alpha}4, were found to be up-regulated (≥30% increase) in N{alpha}s1-/- mice. In addition, N{alpha}s1-/- mice exhibited increased levels of hepatic lipid ({approx}16% increase), serum cholesterol ({approx}20% increase) and LDL ({approx}100% increase), and reduced hepatic glycogen ({approx}50% decrease) levels. In conclusion, these data suggest an altered lipid and cholesterol metabolism in the hyposulfatemic N{alpha}s1-/- mouse, and provide new insights into the metabolic state of the liver in N{alpha}s1-/- mice.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.